Healios Science

Healios Science


Healios’ insights into the potentials of Digital Biomarkers, twinned with RC2NB’s comprehensive clinical research into Multiple Sclerosis, has granted our partnership a unique position of expertise to create the innovative Software Medical Device dreaMS (CE-Mark, class I)

Award winning companion App

Healios Digital Biomarkers are accessible via a proprietary companion app. Each test can capture several data points, or Digital Biomarkers. All together, Healios AG tests can generate over 200 digital biomarkers

Screenshot of the companion app

How does it work?

Register with Healios AG platform

R&D teams register with the Healios platform in order to access protocol planning

  1. Login to Healios AG platform
  2. Schedule test for study participants
  3. Register participants to access the Healios AG companion app
Healios platform

Study participants

Study participants can access Healios Digital Biomarkers by downloading the Healios AG companion App on their phone. Healios support a BYOD approach (Bring Your Own Device) allowing it to make research an easy experience

Healios app
  1. Download Healios AG companion app from the App store or Google play
  2. The App will engage study participants to perform tests on a regular basis. Those tests are fun and engaging and can be performed as often as desired by the research team
  3. Healios AG companion app collects data from smartphone sensors, then sends it to the Healios R&D platform for analysis with its validated algorithms

Digital Biomarkers data is made accessible on Healios Platform

Research teams can access patient study data through the Healios Platform:

  • R&D team can visualise patient data directly on the Healios platform, within days of the test performance
  • R&D team can also download the data and integrate it with their own analytical tools
Participant detail in Healios platform